List of International Projects.xlsx

	A	B	C	D	E	F	G	H
1	Type of Funding	Funding Agency	Funding Programme	Title	Acronym	Individual/Collaborative	Role	Ongoing / Terminated
2	International Public	European Commission	Horizon 2020	Staff Exchange for Novel applications in 19f magnetic resonance imaging	SENATOR	Collaborative	Coordinator	Ongoing
3	International Public	European Commission	Horizon 2020	Epileptogenesis and Epilepsy Network: from genes, synapses and circuits to pave the way for novel drugs and strategies	EpiEpiNet	Collaborative	Coordinator	Ongoing
4	International Private	la Caixa Foundation	la Caixa Health Research	Next-generation CAR-DOT cells for allogeneic adoptive cancer immunotherapy	Allo_CAR_DOT	Collaborative	Coordinator	Ongoing
5	International Private	la Caixa Foundation	la Caixa Health Research	RNA mis-splicing in hypertrophic cardiomyopathy: opportunities for diagnosis and therapy	spliceHCM	Collaborative	Coordinator	Ongoing
6	International Private	la Caixa Foundation	la Caixa Health Research	IL7R in lung cancer development, metastasis and resistance to immune checkpoint inhibitor therapy	IL7R_LungCan	Collaborative	Coordinator	Ongoing
7	International Private	la Caixa Foundation	la Caixa Health Research	Protecting the brain from metastatic breast cancer	BREAST-BRAIN-N-BBB	Collaborative	Coordinator	Ongoing
8	International Private	la Caixa Foundation	la Caixa Health Research	Whole-organism vaccines against P. falciparum and P. vivax malaria with enhanced efficacy and scope	MALVAX+	Collaborative	Coordinator	Ongoing
9	International Public	European Commission	FETOPEN-01-2018-2019-2020	'One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central	NOVIRUSES2BRAIN	Collaborative	Coordinator	Ongoing
10	International Public	European Commission	H2020	Mapping the cities through the senses of those who make them	eMotional brains	Collaborative	Coordinator	Ongoing
11	International Public	European Commission	Horizon Europe	Integrated Services for Infectious Disease Outbreak Research	ISIDORe	Collaborative	Partner	Ongoing
12	International Public	European Commission	Horizon Europe	RNA-BASED ANTI-CANCER IMMUNOTHERAPY	CANCERNA	Collaborative	Partner	Ongoing
13	International Public	European Commission	Horizon 2020	European Network Linking Informatics and Genomics of Helper T cells in Tissues	ENLIGHT-TENplus	Collaborative	Partner	Ongoing
14	International Public	European Commission	NIH	Role of the LANA-MDC1 interaction in vivo	-----------	Collaborative	Partner	Ongoing
15	International Public	European Commission	Horizon 2020	Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance	INNO4COV-19	Collaborative	Partner	Ongoing
16	International Public	European Commission	Horizon 2020	Bringing Artificial Intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis	BRAINTEASER	Collaborative	Partner	Ongoing
17	International Public	European Commission	Horizon 2020	What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation	Cell2Cell	Collaborative	Partner	Ongoing
18	International Public	European Commission	Horizon 2020	Thymic Abnormalities in Rare Immunological Diseases	TARID	Collaborative	Partner	Ongoing
19	International Public	European Commission	Horizon 2020	Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases	IDEA-FAST	Collaborative	Partner	Ongoing
20	International Public	NIH	NIH	Genetic and Biochemical Studies of KSHV LANA	-------	Collaborative	Partner	Ongoing
21	International Public	NIH	NIH	Environmental Mixtures, Cognitive Control and Reward Processes, And Risk for Psychiatric Problems in Adolescence.	-------	Collaborative	Partner	Ongoing
22	International Private	Leducq Foundation	Transatlantic Networks of Excellence		------------	Collaborative	Partner	Ongoing
23	International Public	European Commission	H2020 Industrial leadership	Safety testing in the life cycle of nanotechnology-enabled medical technologies for health	SAFE-N-MEDTECH	Collaborative	Partner	Ongoing
24	International Public	European Commission	H2020 Societal Challenges 1	Comprehending Treatment Responses and Disease Trajectories of 3 Autoimmune Diseases Through a Combination of Approaches	3TR	Collaborative	Partner	Ongoing
25	International Public	European Commission	H2020 Societal Challenges 1	Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases	IDEA-FAST	Collaborative	Partner	Ongoing
26	International Public	European Commission	COST Actions	Catalysing transcriptomics research in cardiovascular disease	CardioRNA	Collaborative	Partner	Ongoing
27	International Public	European Commission	COST Actions	International Nucleome Consortium		Collaborative	Partner	Ongoing
28	International Public	European Commission	Horizon 2020			Collaborative	Partner	Ongoing
29	International Private	Fondation Leducq	Transatlantic Networks of Excellence Program	Arterial flow as attractor for endothelial cell migration – a new concept in vascular malformation and stroke regeneration	ATTRACT	Collaborative	Partner	Ongoing
30	International Public	European Commission	H2020	A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patientswith structural heart disease	BETA3_LVH	Collaborative	Partner	Ongoing
31	International Public	European Commission	H2020	Personalized Prevention for Coronary Heart Disease	COROPREVENTION	Collaborative	Partner	Ongoing
32	International Public	European Commission	H2021	Cyber-Physical Intensive Care Medical System for Covid-19 -	ICU4COVID	Collaborative	Partner	Ongoing
33	International Public	European Commission	H2020	conect4children (COllaborative Network for European Clinical Trials For Children)	C4C	Collaborative	Partner	Ongoing
34	International Public	European Commission	3rd Health Programme	Innovative Immunisation Hubss	ImmuHub	Collaborative	Partner	Ongoing
35	International Public	European Commission	Horizon 2020	Neurologic and Psychiatric Disorders: from synapses to networks	SynaNet	Collaborative	Coordinator	Terminated
36	International Public	European Commission	WIDESPREAD-03-2018		RiboMed	Collaborative	Coordinator	Terminated
37	International Public	European Commission	WIDESPREAD-03-2018		SIMICA	Collaborative	Coordinator	Terminated
38	International Public	European Commission	Horizon 2020	Generating a 3D in vitro innervated and vascularized muscle	MyoChip	Collaborative	Coordinator	Terminated
39	International Public	European Commission	Horizon 2020			Collaborative	Coordinator	Terminated
40	International Public	European Commission	Horizon 2020			Collaborative	Coordinator	Terminated
41	International Public	European Commission	Horizon 2020			Collaborative	Coordinator	Terminated
42	International Public	European Commission	Horizon 2020			Collaborative	Coordinator	Terminated
43	International Public	European Commission	Horizon 2020			Collaborative	Coordinator	Terminated
44	International Public	European Commission	Horizon 2020			Collaborative	Coordinator	Terminated
45	International Public	European Commission	Horizon 2020			Collaborative	Coordinator	Terminated
46	International Public	European Commission	Horizon 2020	Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes	TREGeneration	Collaborative	Coordinator	Terminated
47	International Public	European Commission	Horizon 2020			Collaborative	Coordinator	Terminated
48	International Public	European Commission	FP7		RNPnet	Collaborative	Coordinator	Terminated
49	International Public	European Commission	FP7		STROMA	Collaborative	Coordinator	Terminated
50	International Private	Wellcome Trust	Collaborative Award in Science	Challenging trypanosome antigenic variation paradigms using natural systems		Collaborative	Partner	Terminated
51	International Public	European Commission	Horizon 2020			Collaborative	Partner	Terminated
52	International Public	European Commission	Horizon 2020			Collaborative	Partner	Terminated
53	International Public	European Commission	European Food Safety Authority			Collaborative	Partner	Terminated
54	International Public	European Commission	JPND	ONTology-based Web Database for Understanding Amyotrophic Lateral Sclerosis	ONTWebDUALS	Collaborative	Partner	Terminated
55	International Public	European Commission	Horizon 2020	Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone	FAIR-PARK II	Collaborative	Partner	Terminated
56	International Public	NIH	NIH	Engineering protease-resistant A/B foldamer peptides for broad-spectrum antivirals		Collaborative	Partner	Terminated
57	International Public	European Commission	Horizon 2020			Collaborative	Partner	Terminated
58	International Public	European Commission	FP7		CLASP	Collaborative	Partner	Terminated
59	International Public	European Commission	FP7		COURAGE-PD	Collaborative	Partner	Terminated
60	International Public	European Commission	FP7		RHAPSODY	Collaborative	Partner	Terminated
61	International Public	European Commission	ERA-NET			Collaborative	Partner	Terminated
62	International Public	European Commission	COST Actions		Mye-EUNITER	Collaborative	Partner	Terminated
63	International Public	European Commission	FP7		SENSE-PARK	Collaborative	Partner	Terminated
64	International Public	European Commission	FP7		SOPHIA	Collaborative	Partner	Terminated
65	International Public	European Commission	FP7		BIOMARKADP	Collaborative	Partner	Terminated
66	International Private	Parkinson Society Canada	Parkinson Society Canada			Collaborative	Partner	Terminated
67	International Private	EFSD/Novo Nordisk	EFSD/Novo Nordisk			Collaborative	Partner	Terminated
68	International Private	European Huntington's Disease Network	European Huntington's Disease Network			Collaborative	Partner	Terminated
69	International Public	European Commission	FP7	Consortium to Perform Human Biomonitoring on a European Scale	COPHES	Collaborative	Partner	Terminated
70	International Public	European Commission	FP7	Families and food poverty in three European Countries in an Age of Austerity	FPF	Collaborative	Partner	Terminated
71	International Public	European Commission	H2020	Innovative approach for self-management and social welfare of Cystic Fibrosis patients in Europe: development, validation and implementation of a telematics tool	MyCyFAPP	Collaborative	Partner	Terminated
72	International Public	European Commission	H2020	NEurobehavioural predictiVE and peRsonalised Modelling of depressIve symptoms duriNg primary somatic Diseases with ICT-enabled self-management procedures	NEVERMIND	Collaborative	Partner	Terminated
73	International Public	European Commission	H2020	Implications of Medical Low Dose Radiation Exposure	MEDIRAD	Collaborative	Partner	Terminated
74	International Public	European Commission	Horizon Europe	-------	-------	Individual	N/A	Ongoing
75	International Public	European Commission	Horizon Europe	A microRNA-regulated cell death-inducing gene therapy for T-cell Acute Lymphoblastic Leukemia	miRToTALL	Individual	N/A	Ongoing
76	International Public	European Commission	Horizon 2020	E3-hijacking molecular glues of RNA binding protein IGF2BP1 in ovarian cancer	E3glueRBP	Individual	N/A	Ongoing
77	International Public	European Commission	Horizon 2020	Antibody-based IL-7R targeted therapies	IL7signTHER	Individual	N/A	Ongoing
78	International Public	European Commission	Horizon 2020	Exploring lamin-lipid interactions and the loss of nuclear structural integrity as the molecular determinants of human aging	LipLAge	Individual	N/A	Ongoing
79	International Public	European Commission	Horizon 2020		GammaDeltaTME	Individual	N/A	Ongoing
80	International Public	European Commission	Horizon 2020	Ligand Directed NIR-based Theranostic Prodrugs for Prostate Cancer	ClickandTreatCancer	Individual	N/A	Ongoing
81	International Private	la Caixa Foundation	la Caixa Health Research	Targeting induced-senescent cells: a novel approach to promote spinal cord regeneration in mammals	SENSe	Individual	N/A	Ongoing
82	International Private	la Caixa Foundation	la Caixa Health Research	Enhancing Tissue Resident Immunity	ETERNITY	Individual	N/A	Ongoing
83	International Private	EMBO	Long-Term Fellowships	-------	-------	Individual	N/A	Ongoing
84	International Private	EMBO	Installation Grant	-------	-------	Individual	N/A	Ongoing
85	International Private	la Caixa Foundation	la Caixa Health Research	Mechanism and function of epitranscriptomic poly(A) tail modifications in African trypanosomes	TrypM6A	Individual	N/A	Ongoing
86	International Private	British Heart Foundation	Project Grant	Investigating the causes of mutation-negative hypertrophic cardiomyopathy: Role of cryptic RNA mis- splicing in myosin binding protein C (MYBPC3)	-----------	Individual	N/A	Ongoing
87	International Private	EMBO	Long-Term Fellowships		-----------	Individual	N/A	Ongoing
88	International Private	International Society for Neurochemistry	Career Development Grant	Cannabinoid type 2 receptors as therapeutic targets in depression: role of adult neural stem cells	---------	Individual	N/A	Ongoing
89	International Private	la Caixa Foundation	la Caixa Health Research	Regulatory RNA–protein interactions at telomeres in healthy cells and during malignant transformation	TELOTRANS	Individual	N/A	Ongoing
90	International Private	International Brain Research Organization	IBRO Early Career Awards 2021	New targets for neural plasticity and brain repair: potential of adult neural stem cells	---------	Individual	N/A	Ongoing
91	International Private	International Rett Syndrome Foundation	IBRO Early Career Awards 2022	Exploring the contribution of transposable elements for the pathogenesis of Rett syndrome	---------	Individual	N/A	Ongoing
92	International Private	International Society for Neurochemistry	IBRO Early Career Awards 2023		---------	Individual	N/A	Ongoing
93	International Public	European Commission	ERC-PoC	Selective retention of VEGF for cancer and retinopathies therapeutics	VeCare	Individual	N/A	Terminated
94	International Public	European Commission	MSCA IF		TRYPTISSUE	Individual	N/A	Terminated
95	International Public	European Commission	MSCA IF		ADAPT2FLOW	Individual	N/A	Terminated
96	International Public	European Commission	MSCA IF		EvolSpliceKinetics	Individual	N/A	Terminated
97	International Public	European Commission	ERC		GelGeneCircuit	Individual	N/A	Terminated
98	International Private	National Multiple Scerosis Society	Pilot Grant	Unravelling longitudinal mitochondrial DNA mutations in Multiple Sclerosis: association with disease activity and progression		Individual	N/A	Terminated
99	International Private	Sanofi	Sanofi - Institut Pasteur Awards			Individual	N/A	Terminated
100	International Private	EMBO	Long-Term Fellowship			Individual	N/A	Terminated